These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
376 related articles for article (PubMed ID: 18202831)
1. BCRP/ABCG2 in the placenta: expression, function and regulation. Mao Q Pharm Res; 2008 Jun; 25(6):1244-55. PubMed ID: 18202831 [TBL] [Abstract][Full Text] [Related]
2. An update on expression and function of P-gp/ABCB1 and BCRP/ABCG2 in the placenta and fetus. Han LW; Gao C; Mao Q Expert Opin Drug Metab Toxicol; 2018 Aug; 14(8):817-829. PubMed ID: 30010462 [TBL] [Abstract][Full Text] [Related]
3. Fetoprotective activity of breast cancer resistance protein (BCRP, ABCG2): expression and function throughout pregnancy. Hahnova-Cygalova L; Ceckova M; Staud F Drug Metab Rev; 2011 Feb; 43(1):53-68. PubMed ID: 20854129 [TBL] [Abstract][Full Text] [Related]
4. Breast cancer resistance protein in pharmacokinetics and drug-drug interactions. Xia CQ; Yang JJ; Gan LS Expert Opin Drug Metab Toxicol; 2005 Dec; 1(4):595-611. PubMed ID: 16863427 [TBL] [Abstract][Full Text] [Related]
5. ATP-binding cassette efflux transporters in human placenta. Ni Z; Mao Q Curr Pharm Biotechnol; 2011 Apr; 12(4):674-85. PubMed ID: 21118087 [TBL] [Abstract][Full Text] [Related]
6. Expression and functional activity of breast cancer resistance protein (BCRP, ABCG2) transporter in the human choriocarcinoma cell line BeWo. Ceckova M; Libra A; Pavek P; Nachtigal P; Brabec M; Fuchs R; Staud F Clin Exp Pharmacol Physiol; 2006; 33(1-2):58-65. PubMed ID: 16445700 [TBL] [Abstract][Full Text] [Related]
7. Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense. Leslie EM; Deeley RG; Cole SP Toxicol Appl Pharmacol; 2005 May; 204(3):216-37. PubMed ID: 15845415 [TBL] [Abstract][Full Text] [Related]
8. Role of the breast cancer resistance protein (ABCG2) in drug transport. Mao Q; Unadkat JD AAPS J; 2005 May; 7(1):E118-33. PubMed ID: 16146333 [TBL] [Abstract][Full Text] [Related]
9. Effect of oxygen on multidrug resistance in the first trimester human placenta. Lye P; Bloise E; Dunk C; Javam M; Gibb W; Lye SJ; Matthews SG Placenta; 2013 Sep; 34(9):817-23. PubMed ID: 23790363 [TBL] [Abstract][Full Text] [Related]
10. Anandamide down-regulates placental transporter expression through CB2 receptor-mediated inhibition of cAMP synthesis. Szilagyi JT; Composto-Wahler GM; Joseph LB; Wang B; Rosen T; Laskin JD; Aleksunes LM Pharmacol Res; 2019 Mar; 141():331-342. PubMed ID: 30610963 [TBL] [Abstract][Full Text] [Related]
11. Glucocorticoids modulate multidrug resistance transporters in the first trimester human placenta. Lye P; Bloise E; Nadeem L; Gibb W; Lye SJ; Matthews SG J Cell Mol Med; 2018 Jul; 22(7):3652-3660. PubMed ID: 29691980 [TBL] [Abstract][Full Text] [Related]
12. Effect of prostaglandin E2 on multidrug resistance transporters in human placental cells. Mason CW; Lee GT; Dong Y; Zhou H; He L; Weiner CP Drug Metab Dispos; 2014 Dec; 42(12):2077-86. PubMed ID: 25261564 [TBL] [Abstract][Full Text] [Related]
13. Changes in Expression and Function of Placental and Intestinal P-gp and BCRP Transporters during Pregnancy. Szatmári P; Ducza E Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685897 [TBL] [Abstract][Full Text] [Related]
14. The role of placental breast cancer resistance protein in the efflux of glyburide across the human placenta. Pollex E; Lubetsky A; Koren G Placenta; 2008 Aug; 29(8):743-7. PubMed ID: 18558430 [TBL] [Abstract][Full Text] [Related]
15. Regional expression of the BCRP/ABCG2 transporter in term human placentas. Memon N; Bircsak KM; Archer F; Gibson CJ; Ohman-Strickland P; Weinberger BI; Parast MM; Vetrano AM; Aleksunes LM Reprod Toxicol; 2014 Jan; 43():72-77. PubMed ID: 24269555 [TBL] [Abstract][Full Text] [Related]
16. Structure and function of the human breast cancer resistance protein (BCRP/ABCG2). Ni Z; Bikadi Z; Rosenberg MF; Mao Q Curr Drug Metab; 2010 Sep; 11(7):603-17. PubMed ID: 20812902 [TBL] [Abstract][Full Text] [Related]
17. Protective role of the placental efflux transporter BCRP/ABCG2 in the relationship between prenatal cadmium exposure, placenta weight, and size at birth. Barrett ES; Rivera-Núñez Z; Getz K; Ohman-Strickland P; Zhang R; Kozlosky D; Doherty CL; Buckley BT; Brunner J; Miller RK; O'Connor TG; Aleksunes LM Environ Res; 2023 May; 225():115597. PubMed ID: 36863650 [TBL] [Abstract][Full Text] [Related]
18. The MRP-related and BCRP/ABCG2 multidrug resistance proteins: biology, substrate specificity and regulation. Haimeur A; Conseil G; Deeley RG; Cole SP Curr Drug Metab; 2004 Feb; 5(1):21-53. PubMed ID: 14965249 [TBL] [Abstract][Full Text] [Related]
19. Placental P-glycoprotein and breast cancer resistance protein: influence of polymorphisms on fetal drug exposure and physiology. Hutson JR; Koren G; Matthews SG Placenta; 2010 May; 31(5):351-7. PubMed ID: 20347140 [TBL] [Abstract][Full Text] [Related]
20. Breast cancer resistance protein (BCRP)-mediated glyburide transport: effect of the C421A/Q141K BCRP single-nucleotide polymorphism. Pollex EK; Anger G; Hutson J; Koren G; Piquette-Miller M Drug Metab Dispos; 2010 May; 38(5):740-4. PubMed ID: 20159988 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]